Comparison of Phenylephrine and Ephedrine in the Treatment of Hemodynamic Disorders After Spinal Anesthesia in the Elderly (HypoGer)
Primary Purpose
Hip Fractures, Elderly Patients, Spinal Anesthesia
Status
Completed
Phase
Not Applicable
Locations
Poland
Study Type
Interventional
Intervention
Ephedrine
Phenylephrine
Sponsored by
About this trial
This is an interventional prevention trial for Hip Fractures focused on measuring Hypotension, Phenylephrine, Ephedryne
Eligibility Criteria
Inclusion Criteria:
- elderly (age more than 65 years)
- hip fracture scheduled for lower limb surgery under spinal anesthesia
- spinal anesthesia
Exclusion Criteria:
- contraindications to spinal anesthesia
- participant refusal
- age less than 65
- bradycardia (heart rate less than 60)
- participants unable to give consent or inability to communicate
Sites / Locations
- Infant Jesus Teaching Hospital
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Active Comparator
Arm Label
25 mg of ephedrine
0,3 mg of phenylephrine
Arm Description
participants who will receive intravenous 1,25mg/min ephedrine during 20 minutes (total dosage is 25 mg of ephedrine).
participants who will receive intravenous 0,015mg/min phenylephrine during 20 minutes (total dosage is 0,3mg of phenylephrine).
Outcomes
Primary Outcome Measures
blood preasure (mean arterial pressure, systolic and diastolic blood pressure)
parameter will be measured and recorded every 5 min after spinal anesthesia.
Secondary Outcome Measures
heart rate, expressed in bpm
parameter will be measured using impedance cardiography and recorded every 5 min after spinal anesthesia.
cardiac output, expressed in L/min
parameter will be measured using impedance cardiography and recorded every 5 min after spinal anesthesia.
stroke volume, expressed in ml
parameter will be measured using impedance cardiography and recorded every 5 min after spinal anesthesia.
cardiac index, expressed in L/min/m2, is the ratio of cardiac output to the body surface area.
parameter will be measured using impedance cardiography and recorded every 5 min after spinal anesthesia.
stroke index, expressed in ml/m2, is the ratio of stroke volume to the body surface area.
parameter will be measured using impedance cardiography and recorded every 5 min after spinal anesthesia.
systemic vascular resistance, expressed in Dynes.sec.cm-⁵
parameter will be measured using impedance cardiography and recorded every 5 min after spinal anesthesia.
systemic vascular resistance index, expressed in Dynes.sec.cm-⁵/m2, is the ratio of systemic vascular resistance to the body surface area.
parameter will be measured using impedance cardiography and recorded every 5 min after spinal anesthesia.
stroke volume variation, expressed in percentage (%)
parameter will be measured using impedance cardiography and recorded every 5 min after spinal anesthesia.
systemic oxygen delivery, expressed in ml/min
parameter will be measured using impedance cardiography and recorded every 5 min after spinal anesthesia.
oxygen saturation, expressed in percentage (%)
parameter will be measured using pulse oximetry and recorded every 5 min after spinal anesthesia.
Full Information
NCT ID
NCT03858465
First Posted
February 20, 2019
Last Updated
February 23, 2023
Sponsor
Medical University of Warsaw
1. Study Identification
Unique Protocol Identification Number
NCT03858465
Brief Title
Comparison of Phenylephrine and Ephedrine in the Treatment of Hemodynamic Disorders After Spinal Anesthesia in the Elderly
Acronym
HypoGer
Official Title
Comparison of Phenylephrine and Ephedrine in the Treatment of Hemodynamic Disorders After Spinal Anesthesia in the Elderly
Study Type
Interventional
2. Study Status
Record Verification Date
February 2023
Overall Recruitment Status
Completed
Study Start Date
February 1, 2019 (Actual)
Primary Completion Date
February 24, 2019 (Actual)
Study Completion Date
February 1, 2023 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Medical University of Warsaw
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Spinal anesthesia is often used for lower limb surgery in elderly. Hypotension is a side effect of spinal block. In this study, intravenous ephedrine and phenylephrine will be compared with each other to prevent spinal anesthesia-induced hypotension, which is defined in absolute terms as a systolic blood pressure < 100 mmHg or in relative terms as a 20% fall of systolic blood pressure from baseline.
Detailed Description
Randomized single centre clinical randomized study will be performed on 50 participants. The inclusion criteria are participants (age more than 65 years) with proximal femoral fracture scheduled for lower limb surgery under spinal anesthesia.
The Ethics Committee approved this prospective study. Informed consent will be taken from individual subjects. Participants are randomly allocated into one of the two study groups.
Group A: participants who will receive intravenous 25 mg of ephedrine added to syringe with 50 ml 0,9% sodium chloride solution during 20 minutes. Group B: Phenylephrine 5 mg will be added to syringe with 50 ml 0,9% sodium chloride solution, participants will receive intravenous 0,3 mg of phenylephrine during 20 minutes. Randomization is achieved with the help of Random.org.
In order to reduce pain prior to spinal anesthesia an ultrasound-guided fascia iliaca block will be performed using a volume of 30 ml ropivacaine 0,2%. After skin infiltration with 3 ml of lidocaine, a 25G Pencan spinal needle will be inserted at the L3-L4 or L4-L5 vertebral interspaces. After aspirating cerebrospinal fluid, participants will receive hyperbaric bupivacaine 0.5% at 0,11 mg/cm according to the participant height. Ephedrine and phenylephrine will be given intravenous immediately after injection of bupivacaine. Impedance cardiography will be used to measure hemodynamic parameters: cardiac output, stroke volume, cardiac index, stroke index, systemic vascular resistance, systemic vascular resistance index. Heart rate, blood pressure and oxygen saturation will also be controlled. All these parameters will be measured and recorded every 5 minutes until 30 minutes after spinal anesthesia. The data will be statistically analyzed.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hip Fractures, Elderly Patients, Spinal Anesthesia, Lower Limb Surgery
Keywords
Hypotension, Phenylephrine, Ephedryne
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
50 (Actual)
8. Arms, Groups, and Interventions
Arm Title
25 mg of ephedrine
Arm Type
Active Comparator
Arm Description
participants who will receive intravenous 1,25mg/min ephedrine during 20 minutes (total dosage is 25 mg of ephedrine).
Arm Title
0,3 mg of phenylephrine
Arm Type
Active Comparator
Arm Description
participants who will receive intravenous 0,015mg/min phenylephrine during 20 minutes (total dosage is 0,3mg of phenylephrine).
Intervention Type
Drug
Intervention Name(s)
Ephedrine
Other Intervention Name(s)
Ephedrinum hydrochloricum WZF Polfa Warszawa 25mg/ml
Intervention Description
intravenous 25 mg of ephedrine
Intervention Type
Drug
Intervention Name(s)
Phenylephrine
Other Intervention Name(s)
Phenylephrine Unimedic 10mg/ml
Intervention Description
intravenous 0,3 mg of phenylephrine
Primary Outcome Measure Information:
Title
blood preasure (mean arterial pressure, systolic and diastolic blood pressure)
Description
parameter will be measured and recorded every 5 min after spinal anesthesia.
Time Frame
30 min
Secondary Outcome Measure Information:
Title
heart rate, expressed in bpm
Description
parameter will be measured using impedance cardiography and recorded every 5 min after spinal anesthesia.
Time Frame
30 min
Title
cardiac output, expressed in L/min
Description
parameter will be measured using impedance cardiography and recorded every 5 min after spinal anesthesia.
Time Frame
30 min
Title
stroke volume, expressed in ml
Description
parameter will be measured using impedance cardiography and recorded every 5 min after spinal anesthesia.
Time Frame
30 min
Title
cardiac index, expressed in L/min/m2, is the ratio of cardiac output to the body surface area.
Description
parameter will be measured using impedance cardiography and recorded every 5 min after spinal anesthesia.
Time Frame
30 min
Title
stroke index, expressed in ml/m2, is the ratio of stroke volume to the body surface area.
Description
parameter will be measured using impedance cardiography and recorded every 5 min after spinal anesthesia.
Time Frame
30 min
Title
systemic vascular resistance, expressed in Dynes.sec.cm-⁵
Description
parameter will be measured using impedance cardiography and recorded every 5 min after spinal anesthesia.
Time Frame
30 min
Title
systemic vascular resistance index, expressed in Dynes.sec.cm-⁵/m2, is the ratio of systemic vascular resistance to the body surface area.
Description
parameter will be measured using impedance cardiography and recorded every 5 min after spinal anesthesia.
Time Frame
30 min
Title
stroke volume variation, expressed in percentage (%)
Description
parameter will be measured using impedance cardiography and recorded every 5 min after spinal anesthesia.
Time Frame
30 min
Title
systemic oxygen delivery, expressed in ml/min
Description
parameter will be measured using impedance cardiography and recorded every 5 min after spinal anesthesia.
Time Frame
30 min
Title
oxygen saturation, expressed in percentage (%)
Description
parameter will be measured using pulse oximetry and recorded every 5 min after spinal anesthesia.
Time Frame
30 min
10. Eligibility
Sex
All
Minimum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
elderly (age more than 65 years)
hip fracture scheduled for lower limb surgery under spinal anesthesia
spinal anesthesia
Exclusion Criteria:
contraindications to spinal anesthesia
participant refusal
age less than 65
bradycardia (heart rate less than 60)
participants unable to give consent or inability to communicate
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Rafał Kowalczyk, PhD
Organizational Affiliation
I Department of Anaesthesiology and Intensive Care, Infant Jesus Teaching Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Infant Jesus Teaching Hospital
City
Warsaw
ZIP/Postal Code
02-005
Country
Poland
12. IPD Sharing Statement
Plan to Share IPD
Undecided
IPD Sharing Plan Description
Primary and secondary outcomes will be available
Citations:
PubMed Identifier
27995106
Citation
Abbasivash R, Sane S, Golmohammadi M, Shokuhi S, Toosi FD. Comparing prophylactic effect of phenylephrine and ephedrine on hypotension during spinal anesthesia for hip fracture surgery. Adv Biomed Res. 2016 Oct 26;5:167. doi: 10.4103/2277-9175.190943. eCollection 2016.
Results Reference
background
Learn more about this trial
Comparison of Phenylephrine and Ephedrine in the Treatment of Hemodynamic Disorders After Spinal Anesthesia in the Elderly
We'll reach out to this number within 24 hrs